Abdullah, N.; Tamimi, Y.; Dobretsov, S.; Balushi, N.A.; Alshekaili, J.; Al Balushi, H.; Al Kindi, M.; Hassan, S.I.; Bahlani, S.A.; Tsang, B.K.;
et al. Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis. Molecules 2021, 26, 3624.
https://doi.org/10.3390/molecules26123624
AMA Style
Abdullah N, Tamimi Y, Dobretsov S, Balushi NA, Alshekaili J, Al Balushi H, Al Kindi M, Hassan SI, Bahlani SA, Tsang BK,
et al. Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis. Molecules. 2021; 26(12):3624.
https://doi.org/10.3390/molecules26123624
Chicago/Turabian Style
Abdullah, Nada, Yahya Tamimi, Sergey Dobretsov, Najwa Al Balushi, Jalila Alshekaili, Hamed Al Balushi, Mahmood Al Kindi, Syed Imran Hassan, Shadia Al Bahlani, Benjamin K. Tsang,
and et al. 2021. "Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis" Molecules 26, no. 12: 3624.
https://doi.org/10.3390/molecules26123624
APA Style
Abdullah, N., Tamimi, Y., Dobretsov, S., Balushi, N. A., Alshekaili, J., Al Balushi, H., Al Kindi, M., Hassan, S. I., Bahlani, S. A., Tsang, B. K., & Burney, I. A.
(2021). Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis. Molecules, 26(12), 3624.
https://doi.org/10.3390/molecules26123624